AtriCure Inc
ATRC36.660USD
+1.650+4.71%
收盘 09/18, 16:00（美东）报价延迟15分钟
1.82B总市值
亏损市盈率 TTM
关于 AtriCure Inc 公司
AtriCure, Inc. 提供治疗心房颤动 (Afib)、左心耳 (LAA) 管理和术后疼痛管理的技术。该公司的心脏消融和左心耳管理 (LAAM) 产品供医生在开胸和微创外科手术中使用。其疼痛管理解决方案供医生在心胸外科或胸外科手术过程中冻结神经。该公司的开放式和微创消融产品包括 Isolator Synergy 夹钳和多功能笔和线性消融设备。其开放式消融产品包括 cryoICE 冷冻消融系统。其微创消融产品包括采用 VisiTrax 技术的 EPi-Sense 引导凝血系统。其附属物管理产品包括 AtriClip 系统。Isolator Synergy 消融系统夹钳是一次性使用的射频 (RF) 产品，其钳口以平行方式闭合。
公司简介
公司代码ATRC
公司名称AtriCure Inc
上市日期Aug 05, 2005
CEOMr. Michael H. (Mike) Carrel, CPA
员工数量1300
证券类型Ordinary Share
年结日Aug 05
公司地址7555 Innovation Way
城市MASON
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编45040
电话15137554100
网址https://www.atricure.com
公司代码ATRC
上市日期Aug 05, 2005
CEOMr. Michael H. (Mike) Carrel, CPA
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-6.78%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+32.18%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+41.20%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
其他
12.28M
9.94%
地区USD
名称
营收
占比
United States
101.15M
81.82%
Europe
14.20M
11.49%
Asia
6.78M
5.49%
Other international
1.49M
1.20%
业务
地区
业务USD
名称
营收
占比
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
其他
12.28M
9.94%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.85%
Wellington Management Company, LLP
7.99%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.94%
Hood River Capital Management LLC
6.16%
其他
61.88%
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.85%
Wellington Management Company, LLP
7.99%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.94%
Hood River Capital Management LLC
6.16%
其他
61.88%
股东类型
持股股东
占比
Investment Advisor
52.33%
Investment Advisor/Hedge Fund
39.16%
Hedge Fund
5.88%
Individual Investor
3.50%
Research Firm
1.63%
Pension Fund
0.81%
Bank and Trust
0.65%
Family Office
0.07%
Venture Capital
0.04%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
533
52.65M
105.93%
-5.83M
2025Q1
544
53.44M
107.95%
-4.07M
2024Q4
526
50.00M
102.31%
-11.07M
2024Q3
522
53.78M
110.47%
-8.64M
2024Q2
511
54.11M
111.85%
-4.03M
2024Q1
517
53.02M
109.65%
-1.47M
2023Q4
515
50.20M
105.93%
-1.70M
2023Q3
504
48.87M
103.22%
-3.82M
2023Q2
499
48.88M
103.48%
-3.46M
2023Q1
503
48.62M
102.63%
-1.48M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
4.70M
9.5%
+61.17K
+1.32%
Mar 31, 2025
AllianceBernstein L.P.
3.68M
7.43%
-158.60K
-4.14%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.57M
7.21%
-92.41K
-2.52%
Mar 31, 2025
Hood River Capital Management LLC
3.00M
6.06%
+75.48K
+2.58%
Mar 31, 2025
Macquarie Investment Management
2.44M
4.92%
+61.60K
+2.59%
Mar 31, 2025
Champlain Investment Partners, LLC
2.14M
4.32%
-390.65K
-15.45%
Mar 31, 2025
State Street Global Advisors (US)
1.28M
2.58%
-68.53K
-5.09%
Mar 31, 2025
Neuberger Berman, LLC
1.19M
2.4%
+246.88K
+26.29%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.17M
2.36%
+16.11K
+1.40%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
